| Impact of newly diagnosed diabetes on coronavirus disease 2019 severity and hyperglycemia M Uchihara, R Bouchi, N Kodani, S Saito, Y Miyazato, K Umamoto, ... Journal of Diabetes Investigation 13 (6), 1086-1093, 2022 | 13 | 2022 |
| Clinical management and outcomes associated with etoposide, doxorubicin, and cisplatin plus mitotane treatment in metastatic adrenocortical carcinoma: a single institute experience M Uchihara, M Tanioka, Y Kojima, T Nishikawa, K Sudo, T Shimoi, ... International Journal of Clinical Oncology 26 (12), 2275-2281, 2021 | 11 | 2021 |
| Chylous ascites due to hyperthyroidism and heart failure M Uchihara, J Ehara, K Iwanami, K Kitamura, T Suzuki, N Ishizuka, ... Internal Medicine 61 (13), 1995-1998, 2022 | 5 | 2022 |
| Association of acute‐to‐chronic glycemic ratio and outcomes in patients with COVID‐19 and undiagnosed diabetes mellitus: A retrospective nationwide cohort study M Uchihara, T Sugiyama, R Bouchi, N Matsunaga, Y Asai, H Gatanaga, ... Journal of Diabetes Investigation 14 (4), 623-629, 2023 | 3 | 2023 |
| Immunohistochemical Profiling of SSTR2 and HIF-2α with the Tumor Microenvironment in Pheochromocytoma and Paraganglioma M Uchihara, A Tanabe, Y Kojima, T Shimoi, AM Maeshima, K Umamoto, ... Cancers 16 (12), 2191, 2024 | 2 | 2024 |
| Glycemic control using intermittently scanned continuous glucose monitoring in patients with diabetes requiring methylprednisolone therapy for severe COVID-19 M Uchihara, N Kodani, R Bouchi, S Saito, Y Miyazato, H Sugimoto, ... Global Health & Medicine 4 (6), 336-340, 2022 | 2 | 2022 |
| Immunohistochemical profiling of HIF-2 [alpha] and SSTR2 with the tumor microenvironment in metastatic pheochromocytoma and paraganglioma M Uchihara, A Tanabe, Y Kojima, T Shimoi, A Maeshima, K Umamoto, ... Endocrine Abstracts 99, 2024 | | 2024 |
| Clinical Issues and Suggestions: Dashboard Visualization of the Trajectory of Patients with Malignant Hormone-Producing Tumors for Precision Medicine M Uchihara, A Tanabe, H Kajio 2023 Workshop on Visual Analytics in Healthcare (VAHC), 47-49, 2023 | | 2023 |
| Immunohistochemical analysis of somatostatin receptor 2 and the tumor microenvironment in a large set of pheochromocytomas and paragangliomas M Uchihara, A Tanabe, K Umamoto, AM Maeshima, Y Kojima, K Sudo, ... Endocrine Abstracts 90, 2023 | | 2023 |
| Dashboard of Data Visualization Concepts for Patients with Metastatic Adrenocortical Carcinoma M Uchihara, A Tanabe, M Ohsugi, H Kajio | | 2023 |
| ODP624 A case of Cushing disease demonstrated rapid deterioration of clinical findings and marked hypercortisolemia M Hashimoto, H Kajio, M Uchihara, A Tanabe Journal of the Endocrine Society 6 (Suppl 1), A520, 2022 | | 2022 |
| Glycaemic control using intermittently scanned CGM in severe COVID-19 patients with diabetes requiring methylprednisolone therapy: a retrospective observational study M Uchihara, N Kodani, R Bouchi, S Saito, Y Miyazato, N Ihana-Sugiyama, ... DIABETOLOGIA 65 (SUPPL 1), S351-S352, 2022 | | 2022 |
| 薬物治療の update 田辺晶代， 内原正樹， 成瀬光栄 日本内分泌・甲状腺外科学会雑誌 39 (2), 105-109, 2022 | | 2022 |
| O3-4 Etoposide, doxorubicin, and cisplatin with mitotane in metastatic adrenocortical carcinoma in the National Cancer Center M Uchihara, M Tanioka, Y Kojima, A Konno, Y Chiba, T Okuya, ... Annals of Oncology 32, S286, 2021 | | 2021 |
| Suggestion for Research Design: Noninferiority Design in Elderly Patients With Soft-Tissue Sarcoma M Uchihara, K Yoshimura, A Shimomura, Y Kawamura, C Shimizu Journal of Clinical Oncology 39 (7), 862-863, 2021 | | 2021 |
